Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Laurus Labs LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:540222NSE Symbol: LAURUSLABSP/E(TTM):107.78
ISIN Demat:INE947Q01028Div & Yield %:0.09EPS(TTM):4.15
Book Value(Rs):78.057879Market Cap ( Cr.):24107.94Face Value(Rs):2
    Change Company 
( In Cr)
 Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018
INCOME :      
Sales Turnover 5773.454707.044768.722797.342236.152039.29
Excise Duty0.000.000.000.000.0012.45
Net Sales5773.454707.044768.722797.342236.152026.84
Other Income 15.9521.5527.325.8116.1328.84
Stock Adjustments -40.82218.62296.45218.0928.9225.11
Total Income5748.584947.215092.493021.242281.202080.79
EXPENDITURE :      
Raw Materials 2671.652427.182471.581620.641237.851081.51
Power & Fuel Cost301.10188.52149.69132.62105.5090.54
Employee Cost 477.88417.57364.83299.90256.85218.24
Other Manufacturing Expenses 431.99326.34298.12191.38151.49128.72
Selling and Administration Expenses 323.95265.52260.60190.04145.00117.75
Miscellaneous Expenses 44.3015.3310.4810.6216.926.44
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure4250.873640.463555.302445.201913.611643.20
Operating Profit1497.711306.751537.19576.04367.58437.58
Interest 145.7095.8665.9287.7185.8375.44
Gross Profit1352.011210.891471.27488.33281.75362.14
Depreciation300.58235.48196.64183.85160.53121.23
Profit Before Tax1051.43975.411274.63304.48121.22240.91
Tax270.78231.42334.9853.0024.8352.97
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax20.27-6.10-16.46-15.571.3914.80
Reported Net Profit760.38750.09956.11267.0594.99173.14
Extraordinary Items -0.14-0.85-0.63-0.67-0.62-0.37
Adjusted Net Profit760.52750.94956.74267.7295.61173.51
Adjst. below Net Profit 0.000.000.00-3.50-3.270.00
P & L Balance brought forward2577.181912.951031.88803.63727.81573.76
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 107.4785.8675.0435.3015.9019.09
P & L Balance carried down3230.092577.181912.951031.88803.63727.81
Dividend107.4785.8675.0416.040.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %100.00100.00100.0025.0015.0015.00
Earnings Per Share-Unit Curr14.1213.9617.8224.988.9216.33
Earnings Per Share(Adj)-Unit Curr14.1213.9617.825.001.783.27
Book Value-Unit Curr75.3163.0550.54169.84149.47142.72